Abstract TH110: Coordinated Plasma and Kidney Proteomics Reprogramming Supports Sustained Blood Pressure Reduction After RAS Inhibition Withdrawal in Spontaneously Hypertensive Rats
Hypertension · 2026-10 · 83 (Suppl_1)
DOI: 10.1161/hyp.83.suppl_1.th110 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hypertension, 2026-10. Verfasst von Reza Parvan und 10 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Experimental studies suggested that short-term renin-angiotensin system (RAS) inhibition early in life may prevent hypertension development later in life. One injection of angiotensinogen (AGT) siRNA produced long-lasting (>6 months) blood pressure-lowering effects, and this effect was enhanced when combined with an angiotensin receptor blocker (ARB). Here, we investigated to what degree these effects remain (and, if so, through which mechanism) upon acute cessation of treatment.
Methods
Ten-week-old spontaneously hypertensive rats (SHR) were treated with 10 mg/kg AGT-siRNA + 4 mg/kg/day of the ARB valsartan. After 3 weeks, valsartan treatment was discontinued, and AGT-REVERSIR was administered to reverse siRNA silencing. Animals were studied for one more week. Mean arterial blood pressure (MAP) was monitored using radiotelemetry, and circulating AGT and renin were quantified. A multi-layer omics approach, including proteomics, phosphoproteomics, and RNA-seq, was performed in renal tissue and plasma.
Results
Treatment lowered AGT by >99%, and increased renin >100-fold, resulting in a MAP reduction of >70 mm Hg. After stopping treatment, AGT and renin returned to normal, while MAP remained lowered by >30 mm Hg. Kidney proteomic and phosphoproteomic analysis revealed downregulation of Abcd4, Acad10, Lyplal1, Slc15a2, Slc5a9, Slc22a4, Mthfr, Megf9, and upregulation of Capg, Lnpep, Gstm1, Aqp4, Tsc22d4, Map1b, Actr1b, and Farp2 upon drug removal compared to untreated SHRs. Mendelian randomization analysis confirmed their causal link to hypertension. Moreover, gene ontology analysis revealed the enrichment of renin secretion, cGMP-PKG signaling, aldosterone-regulated sodium reabsorption, and AMPK signaling pathways in the kidney after stopping treatment. Interestingly, the Nfatc4 transcription factor (TF) showed a lower phosphorylation level upon treatment discontinuation, which may play a regulatory role in renin secretion via shared TF-binding sites with AP1. Protein levels of factors that affect endothelial remodeling (Angptl8, Apoa5, Apoc4, Cspg4, GPC1, Hrgl1, and Susd5) were decreased in plasma upon drug removal compared to untreated SHRs.
Conclusion
The persistence of low blood pressure after stopping AGT siRNA+valsartan treatment relates to the lasting effects induced by such treatment. A cluster of genes with a causal relationship with hypertension was identified in the kidney, which might help to identify novel targets to treat hypertension. Moreover, the plasma proteome carries a reflection of the memory state induced in the vascular wall.
Zitieren
APA
Parvan, R., Cruz-Lopez, E. O., Molenaar, B., veghel, R. V., Garrelds, I., Wassarman, K., Tu, H., Zlatev, I., Aboumsallem, J. P., Boer, R. A. D., & Danser, J. (2026). Abstract TH110: Coordinated Plasma and Kidney Proteomics Reprogramming Supports Sustained Blood Pressure Reduction After RAS Inhibition Withdrawal in Spontaneously Hypertensive Rats. Hypertension, 83(Suppl_1). https://doi.org/10.1161/hyp.83.suppl_1.th110
Vancouver
Parvan R, Cruz-Lopez EO, Molenaar B, veghel RV, Garrelds I, Wassarman K, et al. Abstract TH110: Coordinated Plasma and Kidney Proteomics Reprogramming Supports Sustained Blood Pressure Reduction After RAS Inhibition Withdrawal in Spontaneously Hypertensive Rats. Hypertension. 2026;83(Suppl_1). doi:10.1161/hyp.83.suppl_1.th110
BibTeX
@article{Parvan2026,
author = {Parvan, Reza and Cruz-Lopez, Edwyn O and Molenaar, Bas and veghel, Richard Van and Garrelds, Ingrid and Wassarman, Kelly and Tu, Ho-Chou and Zlatev, Ivan and Aboumsallem, Joseph Pierre and Boer, Rudolf A De and Danser, Jan},
title = {Abstract TH110: Coordinated Plasma and Kidney Proteomics Reprogramming Supports Sustained Blood Pressure Reduction After RAS Inhibition Withdrawal in Spontaneously Hypertensive Rats},
journal = {Hypertension},
year = {2026},
volume = {83},
number = {Suppl_1},
doi = {10.1161/hyp.83.suppl_1.th110}
}
EUVIMED